El editor solo permite decargar el artículo en su versión post-print desde el repositorio. Por favor, si usted posee dicha versión, enviela a
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor


The inotropic effects of isoproterenol (ISO), as well as the β-adrenoceptors population, were measured in cardiac tissues from normal and short-term (3 days) diabetic rats. ISO increased the tension of both normal and diabetic ventricles, but the efficacy (Emax) of the concentration-response curve was greater on ventricles from diabetic rats than in those from the normal control. This phenomenon was accompanied by a decrease in the number of β-adrenoceptor sites (Bmax) during diabetes. Insulin-treated diabetic hearts partially reversed the phenomenon. Propanolol blocked, in a competitive manner, the positive inotropic action of ISO in both types of ventricles. Inhibition of the synthesis and receptors of thromboxane (TX) reduced the hyperreactivity to ISO and increased the number of β-adrenoceptors during diabetes, producing Bmax values almost similar to those of the normal heart. Additionally, the diabetic heart generated and released a greater amount of TXB2 than the normal heart, even in the presence or absence of ISO. The stimulatory effect of ISO upon TXB2 release was altered by the specific β-adrenergic blockade and by verapamil. In addition, the drugs able to induce a sustained increase of endogenous cAMP also inhibited the release of TXB2 by diabetic ventricles. Exogenous TXB2 exerted the same type of hyperreactivity in diabetic ventricles. This phenomenon was accompanied by an inhibition of Na+ + K+-ATPase activity. These results suggest that β-adrenergic inotropic stimulation is secondary to receptor-mediated hydrolysis of arachidonic acid with subsequent release of thromboxanes, which, in turn, may be responsible for both the superreactivity and the decrease in the number of β-adrenoceptors during diabetes. The abnormal reactivity to β-agonists also could be associated with alterations of the diabetic cardiac Na+ + K+-ATPase activity induced by TXB2 whose production is increased during diabetes. © 1989.


Documento: Artículo
Título:Role of thromboxanes in alterations of the diabetic β-adrenergic system
Autor:Wald, M.; Pascual, J.; Sterin-Borda, L.
Filiación:Centro de Estudios Farmacologicos y de Principios Naturales (CEFAPRIN), Consejo Nacional de Investigaciones Cientificas y Tecnicas de la Republica Argentina (CONICET), 1414 Buenos Aires, Argentina
Palabras clave:7 [5 (4 biphenylylmethoxy) 2 morpholino 3 oxocyclopentyl] 4 heptenoic acid; adenosine triphosphatase (potassium sodium); beta adrenergic receptor; bucladesine; cyclic amp; dihydroalprenolol; imidazole; insulin; isoprenaline; nictindole; propranolol; radioisotope; theophylline; thromboxane b2; verapamil; animal cell; animal experiment; animal model; drug concentration; drug receptor binding; enzyme activity; heart ventricle contractility; male; nonhuman; priority journal; rat; receptor density; streptozocin diabetes; Animal; Biphenyl Compounds; Diabetes Mellitus, Experimental; Dihydroalprenolol; Isoproterenol; Male; Myocardial Contraction; Na(+)-K(+)-Exchanging ATPase; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Support, Non-U.S. Gov't; Thromboxane B2
Página de inicio:3347
Página de fin:3355
Título revista:Biochemical Pharmacology
Título revista abreviado:Biochem. Pharmacol.
CAS:7 [5 (4 biphenylylmethoxy) 2 morpholino 3 oxocyclopentyl] 4 heptenoic acid, 81443-73-4; bucladesine, 16980-89-5, 362-74-3; cyclic AMP, 60-92-4; dihydroalprenolol, 60106-89-0; imidazole, 1467-16-9, 288-32-4; insulin, 9004-10-8; isoprenaline, 299-95-6, 51-30-9, 6700-39-6, 7683-59-2; nictindole, 36504-64-0; propranolol, 13013-17-7, 318-98-9, 3506-09-0, 4199-09-1, 525-66-6; theophylline, 58-55-9, 5967-84-0, 8055-07-0, 8061-56-1, 99007-19-9; thromboxane B2, 54397-85-2; verapamil, 152-11-4, 52-53-9; AH 23848, 81443-73-4; Biphenyl Compounds; Dihydroalprenolol, 60106-89-0; Isoproterenol, 7683-59-2; Na(+)-K(+)-Exchanging ATPase, EC; Receptors, Adrenergic, beta; Thromboxane B2, 54397-85-2


  • Foy, Lucas, Effect of experimental diabetes, food deprivation and genetic obesity on the sensitivity of pithed rats to automatic agents (1976) Br J Pharmacol, 57, pp. 229-234
  • Foy, Lucas, Comparison between spontaneously beating atria from control and steptozocin-diabetic rats (1978) J Pharm Pharmacol, 30, pp. 558-562
  • Heylinger, Pierce, Singal, Beamish, Dhalla, Cardiac and adrenergic receptor alterations in diabetic cardiomyopathy (1982) Basic Res Cardiol, 77, pp. 610-618
  • Ingebretsen, Jr., Peralta, Monsher, Wagner, Ingebretsen, Diabetes alters the myocardial cAMP-protein kinase cascade system (1981) Am J Physiol, 240, pp. H375-H382
  • Sundaresan, Sharma, Gingold, Banerjee, Decreased β-adrenergic receptors in rat heart in streptozotocin-induced diabetes: role of thyroid hormones (1984) Endocrinology, 114, pp. 1358-1363
  • Ingebretsen, Hawelu-Johson, Ingebretsen, Alloxan-induced diabetes reduces β-adrenergic-receptor number without affecting adenylate cyclase in rat ventricular membranes (1983) J Cardiol Pharmacol, 5, pp. 454-461
  • Latifpour, McNeill, Cardiac autonomic receptors: effect of long-term experimental diabetes (1984) J Pharmacol Exp Ther, 230, pp. 242-249
  • Ramanadham, Decker, Tehher, Effect of insulin replacement on streptozotocin-induced effects on the rat heart (1983) Life Sci, 33, pp. 289-296
  • Atkins, Dowell, Love, β-Adrenergic receptors, adenylate cyclase activity, and cardiac dysfunction in the diabetic rat (1985) J Cardiovasc Pharmacol, 7, pp. 66-70
  • Savarese, Berkowitz, β-Adrenergic receptor decrease in diabetic rat hearts (1979) Life Sci, 25, pp. 2075-2078
  • Ramanadham, Tenner, Alterations in the myocardial β-adrenoceptor system of streptozotocin-diabetic rats (1987) Eur J Pharmacol, 136, pp. 377-381
  • Michel, Cros, McNeill, Serrano, Cardiac adenylate cyclase activity in streptozotocin-treated rats after 4 months of diabetes: impairment of epinephrine and glucagon stimulation (1985) Life Sci, 37, pp. 2067-2075
  • Ingebretsen, Moreau, Hawelu-Johnson, Ingebretsen, Jr, Performance of diabetic rat hearts: effects of anoxia and increased work (1980) Am J Physiol, 239, pp. H614-H620
  • Menahan, Chaudhuri, Weber, Shipp, Lack of epinephrine stimulation of rat heart adenylate cyclase m experimental diabetes (1977) Harm Metab Res, 9, pp. 527-528
  • Metz, Feedback modulation of glucose-induced insulin secretion by arachidonic acid metabolites: possible molecular mechanisms and relevance to diabetes mellitus (1981) Prostaglandins Med, 7, pp. 581-589
  • Chen, Robertson, Effects of prostaglandin synthesis inhibitors on human insulin secretion and carbohydrate tolerance (1979) Prostaglandins, 18, pp. 557-567
  • Lapetina, Regulation of arachidonic acid production: Role of phospholipases C and A2 (1982) Trends Pharmacol Sci, 3, pp. 115-118
  • Moncada, Vane, Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis (1978) Br Med Bull, 34, pp. 129-134
  • Katayama, Inaba, Maruno, Omoto, Kawazu, Ishu, Increased TXB2 excretion in diabetes mellitus (1987) J Lab Clin Med, 109, pp. 711-717
  • Fujüi, Sonia, Huang, Manku, Horrobin, Increased release of prostaglandins from the mesenteric vascular bed of diabetic animals the effects of glucose and insulin (1986) Prostaglandins, Leukotrienes and Medicine, 24, pp. 151-161
  • Canga, Sterin-Borda, Hypersensitivity to methoxamine in atria isolated from streptozotocin-induced diabetic rats (1986) Br J Pharmacol, 87, pp. 157-165
  • Canga, Sterin-Borda, Borda, Peredo, Gimeno, The positive inotropic effect of sodium arachidonate on auricles from diabetic rats (1984) European Journal of Pharmacology, 110, pp. 47-54
  • Van, Cumulative dose-response curves.II: Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters (1963) Arch Int Pharmacodyn Ther, 143, pp. 299-319
  • Limas, Limas, Reduced number of beta-adrenergic receptors in myocardium of spontaneously hypertensive rats (1978) Biochem Biophys Res Commun, 83, pp. 710-713
  • Borda, Pascual, Cossio, Arana, Sterin-, Circulating IgG in Chagas' disease which binds to beta-adrenoceptors of myocardium and modulates their activity (1984) Clin Exp Immunol, 57, pp. 679-686
  • Pascual, Borda, Cossio, Arana, Sterin-Borda, Modification of sarcolemmal enzymes by chagasic IgG and its effect on cardiac contractility (1986) Biochem Pharmacol, 35, pp. 3839-3845
  • Liu, Onji, Kinetic characteristics of K+-activated para-nitrophenylphosphatase in isolated adult dog heart myocytes (1980) J Mol Cell Cardiol, 12, pp. 1427-1439
  • Poole, Liu, Landneid, Kinetic studies of the Na+ + K+-ATPase enzyme system in brain and heart of aging rats (1984) Am J Physiol, 247, pp. R850-R855
  • Sagripanti, Santa, Calvo, A simple computer program for Scatchard plot analysis of hormone receptors (1984) Acta Physiol Pharmacol Latinoam, 34, pp. 45-53
  • Pierce, Dhalla, Sarcolemmal Na+ + K+-ATPase activity in diabetic rat heart (1983) Am J Physiol, 245, pp. C241-C247
  • Borda, Pascual, Wald, Sterin-Borda, Hypersensitivity to calcium associated with an increase in sarcolemmal Ca+-ATPase activity in diabetic rat heart (1988) Can J Cardiol, 4, pp. 97-101
  • Moncada, Bunting, Mullane, Thorogood, Vane, Paz, Needleman, Imidazole: a selective potent antagonist of thromboxane synthetase (1977) Prostaglandins, 13, pp. 611-618
  • Gryglewski, Prostaglandin and thromboxane biosynthesis inhibitors (1977) Naunyn-Schmiedebergs Archives of Pharmacology, 297, pp. 585-588
  • Carrier, Edwards, Aronstam, Cholingergic supersensitivity and decreased number of muscarinic receptors in atria from short-term diabetic rats (1984) J Mol Chem Cardiol, 16, pp. 963-972
  • Jackson, McGrath, McNeill, Alteration in alpha1-adrenoceptor stimulation of isolated atria from experimental diabetic rats (1986) Can J Physiol Pharmacol, 64, pp. 145-151
  • Wald, Borda, Sterin-Borda, α-adrenergic supersensitivity and decreased number of β-adrenoceptors in heart from acute diabetic rats (1988) Can J Physiol Pharmacol, 66, pp. 1154-1160
  • Williams, Schaible, Scheuer, Kennedy, Effects of experimental diabetes on adrenergic and cholinergic receptors of rat myocardium (1983) Diabetes, 32, pp. 881-886
  • Canga, Sterin-Borda, Increase in atrial contractility induced by PGE2 in diabetic rats (1986) Pharmacol Res Commun, 18, pp. 371-384
  • Canga, Gorelik, Sterin-Borda, Diabetes alters the reactivity of myocardium to a thromboxane analogue (1987) Can J Physiol Pharmacol, 65, pp. 499-507
  • Terin-Borda, Gimeno, Borda, del, Gimeno, PGI2 and U-46619 stimulate coronary arteries from diabetic dogs and their action is influenced by inhibitors of prostaglandin biosynthesis (1981) Prosta-glandins, 22, pp. 267-278
  • Seager, Singal, Orchard, Pierce, Dhalla, Cardiac cell damage: A primary myocardial disease in streptozotocin-induced chronic diabetes (1984) Br J Exp Pathol, 65, pp. 613-623
  • Schwartz, Lindenmayer, Allen, The sodium-potassium adenosine triphosphatase pharmacological physiological and biochemical aspects (1975) Pharmacol Rev, 27, pp. 3-134


---------- APA ----------
Wald, M., Pascual, J. & Sterin-Borda, L. (1989) . Role of thromboxanes in alterations of the diabetic β-adrenergic system. Biochemical Pharmacology, 38(19), 3347-3355.
---------- CHICAGO ----------
Wald, M., Pascual, J., Sterin-Borda, L. "Role of thromboxanes in alterations of the diabetic β-adrenergic system" . Biochemical Pharmacology 38, no. 19 (1989) : 3347-3355.
---------- MLA ----------
Wald, M., Pascual, J., Sterin-Borda, L. "Role of thromboxanes in alterations of the diabetic β-adrenergic system" . Biochemical Pharmacology, vol. 38, no. 19, 1989, pp. 3347-3355.
---------- VANCOUVER ----------
Wald, M., Pascual, J., Sterin-Borda, L. Role of thromboxanes in alterations of the diabetic β-adrenergic system. Biochem. Pharmacol. 1989;38(19):3347-3355.